Nova Announces Proposed Private Offering of $500 Million of 0.00% Convertible Senior Notes due 2030

Rhea-AI Summary

Nova (NASDAQ: NVMI), a semiconductor metrology solutions provider, has announced plans to offer $500 million in 0.00% Convertible Senior Notes due 2030 through a private offering to qualified institutional buyers. The initial purchasers will have an option to buy an additional $75 million in notes.

The Notes will mature on September 15, 2030, with conversion options available under certain conditions. Nova plans to enter into capped call transactions to reduce potential dilution. The company intends to use the proceeds for general corporate purposes, including potential M&A activities and new product development.

Positive

• Potential to raise up to $575 million in capital through the offering
• Strategic implementation of capped call transactions to minimize shareholder dilution
• Zero interest rate (0.00%) on the convertible notes reduces interest expense burden
• Strengthened financial position for M&A opportunities and product development

Negative

• Potential future dilution of existing shareholders if notes are converted to shares
• Addition of $500 million in debt to the company's balance sheet
• Complex derivative transactions may impact stock price volatility

Insights

Financial Markets Specialist

Nova's $500M zero-interest convertible note offering provides significant acquisition capital while using capped call transactions to minimize dilution risks.

Nova's proposed $500 million convertible note offering (with potential $75 million upsize) represents a strategic financing maneuver that merits close examination. The 0.00% interest rate is particularly noteworthy - the company isn't obligated to make regular interest payments, significantly reducing cash outflow obligations compared to traditional debt. This structure suggests Nova's strong negotiating position and positive market perception.

The conversion features are crafted to provide Nova with substantial flexibility. Conversion rights that only activate under specific conditions until June 2030 give the company nearly five years of protection against unpredictable dilution. The redemption provisions, particularly the ability to redeem after September 2028 if share prices reach 130% of conversion value, provide Nova with strategic optionality to manage its capital structure.

Most sophisticated investors will recognize the importance of the capped call transactions Nova plans to execute alongside this offering. These financial instruments effectively raise the conversion premium for shareholders, substantially reducing potential dilution if Nova's stock appreciates significantly. This hedging strategy demonstrates management's commitment to protecting existing shareholders while still accessing significant capital.

The stated use of proceeds for "general corporate purposes, including potential mergers and acquisitions" signals Nova's strategic intent to expand beyond organic growth. Given Nova's position in the semiconductor metrology and process control market, this capital raise potentially positions the company to acquire complementary technologies that could strengthen its competitive position in advanced semiconductor manufacturing - a sector experiencing substantial growth driven by AI and high-performance computing demands.

REHOVOT, Israel, Sept. 2, 2025 /PRNewswire/ -- Nova (NASDAQ: NVMI), a leading innovator and a key provider of advanced metrology and process control solutions used in semiconductor manufacturing, today announced its intention to offer, subject to market conditions and other factors, $500 million aggregate principal amount of 0.00% Convertible Senior Notes due 2030 (the "Notes") in a private offering (the "Offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the Offering, Nova expects to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $75 million aggregate principal amount of the Notes.

The final terms of the Notes, including the initial conversion price and certain other terms, will be determined at the time of pricing of the Offering. When issued, the Notes will be senior, unsecured obligations of Nova. The Notes will not bear regular interest, and the principal amount of the Notes will not accrete. The Notes will mature on September 15, 2030, unless earlier repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to June 15, 2030, the Notes will be convertible at the option of the holders of Notes only upon the satisfaction of certain conditions and during certain periods. Thereafter, the Notes will be convertible at any time until the close of business on the second scheduled trading day immediately prior to the maturity date. The Notes will be convertible into cash, ordinary shares of Nova or a combination thereof, with the form of consideration determined at Nova's election (together with cash in lieu of any fractional ordinary share, if applicable).

Nova may redeem for cash (1) all of the Notes at any time on or prior to the 40th scheduled trading day immediately preceding the maturity date if certain tax-related events occur and (2) all or any portion (subject to certain limitations) of the Notes, at any time, and from time to time, on or after September 20, 2028, and on or before the 40th scheduled trading day immediately before the maturity date, at its option at any time and from time to time, if the last reported sale price per share of Nova's ordinary shares has been at least 130% of the conversion price for a specified period of time and certain other conditions are satisfied. The redemption price will be equal to the principal amount of the Notes to be redeemed, plus any accrued and unpaid special interest, if any, to, but excluding, the redemption date.

If certain corporate events that constitute a 'fundamental change' (as defined in the indenture governing the Notes) occur, then, subject to a limited exception, noteholders may require Nova to repurchase all or a portion of their Notes for cash. The repurchase price will be equal to the principal amount of the Notes to be repurchased, plus any accrued and unpaid special interest, if any, to, but excluding, the applicable repurchase date.

In connection with the pricing of the Notes, Nova expects to enter into privately negotiated capped call transactions with one or more of the initial purchasers of the Offering and/or their respective affiliates and/or other financial institutions (in such capacity, the 'Option Counterparties'). The capped call transactions are expected to cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, up to the number of shares of Nova's ordinary shares that will initially underlie the Notes. If the initial purchasers exercise their option to purchase additional Notes, then Nova expects to enter into additional capped call transactions with the Option Counterparties. The capped call transactions are expected to generally reduce the potential dilution to the ordinary shares of Nova upon any conversion of Notes and/or to offset any cash payments Nova is required to make in excess of the principal amount of the converted Notes, as the case may be, in the event that the market price per share of Nova's ordinary shares, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, with such reduction of potential dilution and/or offset of cash payments subject to a cap.

Nova has been advised that, in connection with establishing their initial hedges of the capped call transactions, the Option Counterparties or their respective affiliates expect to enter into various derivative transactions with respect to the ordinary shares of Nova concurrently with or shortly after the pricing of the Notes. This activity could have the effect of increasing (or reducing the size of any decrease in) the market price of the ordinary shares or the Notes at that time. In addition, the Option Counterparties or their respective affiliates may modify or unwind their hedge positions by entering into or unwinding various derivatives with respect to the ordinary shares and/or by purchasing or selling ordinary shares or other securities of Nova in secondary market transactions following the pricing of the Notes and from time to time prior to the maturity of the Notes (and are likely to do so following any conversion of the Notes, any repurchase of the Notes by Nova on any fundamental change repurchase date, any redemption date or any other date on which the Notes are retired by Nova, in each case, if Nova exercises the relevant election under the capped call transactions and in connection with any negotiated unwind or modification of the capped call transactions). This activity could also affect the market price of the ordinary shares of Nova or the Notes, which could affect the ability of holders of Notes to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of the Notes, it could affect the number of ordinary shares, if any, and value of the consideration that holders of Notes will receive upon conversion of the Notes.

Nova intends to use a portion of the net proceeds from the Offering to pay the costs of the capped call transactions. Nova also intends to use the remainder of the net proceeds from the Offering for general corporate purposes, including potential mergers and acquisitions, business development, and the development of new products and technologies. However, Nova has not entered into any agreements for or otherwise committed to any specific acquisitions at this time. If the initial purchasers exercise their option to purchase additional Notes, Nova expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the Option Counterparties. Nova expects to use the remaining net proceeds for general corporate purposes as described above.

The Notes will be offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The offer and sale of the Notes and the ordinary shares of Nova potentially issuable upon conversion of the Notes, if any, have not been, and will not be, registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, the Notes and such ordinary shares, if any, may not be offered or sold in the United States except pursuant to an applicable exemption from such registration requirements.

This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale of, the Notes (or any ordinary shares of Nova issuable upon conversion of the Notes) in any state or jurisdiction in which the offer, solicitation, or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

About Nova:

Nova is a leading innovator and key provider of material, optical and chemical solutions for advanced metrology and process control in semiconductor manufacturing. Nova delivers continuous innovation by providing state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high-precision hardware and cutting-edge software, provides its customers with deep insight into developing and producing the most advanced semiconductor devices. Nova's unique capability to deliver innovative solutions enables its customers to improve performance, enhance product yields, and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices worldwide.

Nova is traded on the Nasdaq and TASE, Nasdaq ticker symbol NVMI.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but not limited to, whether Nova will offer and issue the Notes and the terms of the Notes, the anticipated use of proceeds from the Offering, the conversion price of the Notes, whether Nova will enter into the capped call transactions and expectations regarding actions of the Option Counterparties and their respective affiliates. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: risks related to information technology security threats, sophisticated computer crime, and data privacy; foreign political and economic risks including supply-chain difficulties; regulations that could restrict our operations such as economic sanctions and export restrictions; changes in U.S. trade policies and taxation; indirect effects of the Russia – Ukraine conflict; market instability including inflation and recessionary pressures; risks related to doing business with China; catastrophic events; inability to protect our intellectual property; open source technology exposure, including risks related to artificial intelligence; risks related to the use of artificial intelligence technologies; challenges related to our new ERP system; failure to compete effectively or to respond to rapid technological changes; consolidation in our industry; difficulty in predicting the length and strength of any downturn or expansion period of the market we target; factors that adversely affect the pricing and demand for our product lines; dependency on a small number of large customers; dependency on a single manufacturing facility per product line; dependency on a limited number of suppliers; difficulty in integrating current or future acquisitions; lengthy sales cycle and customer delays in orders; the highly cyclical and competitive nature of the markets we target and we operate in; risks related to conditions in Israel, including Israel's conflicts with Hamas and other parties in the region; risks related to our convertible notes; currency fluctuations; and quarterly fluctuations in our operating results. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the Securities and Exchange Commission on February 20, 2025. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Ltd. does not assume any obligation to update the forward-looking information contained in this press release.

Company Contact:

Guy Kizner, Chief Financial Officer
Tel: +972-73-229-5760
E-mail - investors@novami.com

Investor Relations Contact:

Miri Segal MS-IR LLC
E-mail - msegal@ms-ir.com

Logo: https://mma.prnewswire.com/media/1446151/Nova_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/nova-announces-proposed-private-offering-of-500-million-of-0-00-convertible-senior-notes-due-2030--302543685.html

SOURCE Nova

FAQ

What is the size of Nova's (NVMI) convertible note offering in 2025?

Nova is offering $500 million in Convertible Senior Notes, with an option for initial purchasers to buy an additional $75 million.

When do Nova's (NVMI) 2025 convertible notes mature?

The Notes will mature on September 15, 2030, unless earlier repurchased, redeemed, or converted.

What is the interest rate on Nova's (NVMI) 2030 convertible notes?

The Notes will bear 0.00% regular interest, and the principal amount will not accrete.

How will Nova (NVMI) use the proceeds from the 2025 convertible note offering?

Nova plans to use the proceeds for general corporate purposes, including potential mergers and acquisitions, business development, and development of new products and technologies.

What measures is Nova (NVMI) taking to protect shareholders from dilution?

Nova is entering into capped call transactions designed to reduce potential dilution to ordinary shares upon conversion of the Notes and/or offset cash payments required beyond the principal amount.